Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon
Source: EQS
The issuer is Lonza’s issuer rating is currently BBB+ ( A consortium comprising of
Key Data Issue Size 12-Year Bond: Expected Payment Date: Maturity: 24 April 2036 Issue Price: 98.715 percent Redemption Price: 100 percent Coupon: 3.875 percent p.a. About Lonza Lonza is one of the world’s largest healthcare manufacturing organizations. Working across five continents, our global community of around 18,000 colleagues helps pharmaceutical, biotech and nutrition companies to bring their treatments to market. United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments. Our business is structured to meet our customers' complex needs across four divisions: Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients. Our company generated sales of Lonza Contact Details
Additional Information and Disclaimer Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of All trademarks belong to Lonza and are registered in CH, US and/or EU, or belong to their respective third-party owners and are used only for informational purposes. Privacy Policy link
End of Media Release |
Language: | English |
Company: | |
Münchensteinerstrasse 38 | |
4052 |
|
Phone: | +4161 316 81 11 |
Internet: | www.lonza.com |
ISIN: | CH0013841017 |
Valor: | 1384101 |
Listed: | |
EQS News ID: | 1883085 |
End of News |
|
1883085 17.04.2024 CET/CEST